Providence Swedish experts in the media

Watch this KING5 special to learn more about our experts who are practicing tomorrow's medicine today.

Philanthropy-funded transcutaneous bilimeters spare babies additional pain and anxiety.

Watch this video of recent online event and hear from experts and patients about how this advanced technology is changing lives.

The Prevention4Me assessment is free for every patient at Everett's Providence Comprehensive Breast Center patient. The program will expand over the next few years. Learn more.

Research now shows hormone therapy is a safe and effective treatment during menopause. A women’s health expert at Swedish outlines its benefits and risks.

Swedish’s program, led by dedicated teams, has been recognized a radiopharmaceutical therapy center of excellence.

A cardiologist outlines atrial fibrillation, or AFib, and explains why more people under 65 are being diagnosed with this common heart rhythm disorder.

The antibiotic, pivmecillinam, has been used in Europe for over four decades as the primary treatment for uncomplicated UTIs.

With a rising incidence of breast cancer in young women, the new guidelines recommend screenings begin at age 40.

A team of cardiovascular experts at Swedish performed heart surgery at the annual CRT educational forum, sharing expertise with an international audience.

Swedish is part of a trial that has shown significant promise for the early diagnosis of Parkinson’s.

The study, co-authored by three Swedish oncology experts, found a marked increase in angiosarcoma among women previously treated for cancer.

The procedure using the new TriClip to repair a leaky tricuspid valve was also a first in the Pacific Northwest.

Surgical experts at Swedish are saving lives with procedures and technology that not too long ago would have been considered impossible. Learn more.

A Swedish Foundation-funded device offers realistic patient scenarios for advanced cardiac care team training.

Tofersen, a new drug, is the first gene therapy for a familial form of amyotrophic lateral sclerosis.

An expert at Swedish explains how recently released results from three clinical studies are bringing new hope to people with heart valve disease.

Groundbreaking research designed to assess the effectiveness of CAR-T cell therapy on lupus and multiple sclerosis is in the early stages at Swedish.

Michael Chiorean, M.D., co-director of the IBD Center at Swedish, was an investigator in the study that helped win approval for the new medication.

The OakTree study is looking at a new COVID-19 drug to see if it can shorten the time you have symptoms. Learn more about participating.